Fusarium
is widely distributed in the environment and is involved with plant and animal diseases. In humans, several species and species complexes (SC) are related to fusariosis, i.e.,
F. solani
SC,
F. oxysporum
SC,
F. fujikuroi
SC,
F. dimerum, F. chlamydosporum, F. incarnatum-equiseti
, and
F. sporotrichoides
. We aimed to investigate the susceptibility of
Fusarium
clinical isolates to antifungals and azole fungicides and identify the species. Forty-three clinical
Fusarium
isolates were identified by sequencing translation elongation factor 1-alpha (
TEF1
α) gene. Antifungal susceptibility testing was performed to the antifungals amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole, and the azole fungicides difenoconazole, tebuconazole, and propiconazole. The isolates were recovered from patients with median age of 36 years (range 2–78 years) of which 21 were female. Disseminated fusariosis was the most frequent clinical form (
n
= 16, 37.2%) and acute lymphoblastic leukemia (
n
= 7; 16.3%) was the most commonly underlying condition. A few species described in
Fusarium solani
SC have recently been renamed in the genus
Neocosmospora
, but consistent naming is yet not possible.
Fusarium keratoplasticum
FSSC 2 (
n
= 12) was the prevalent species, followed by
F. petroliphilum
FSSC 1 (
n
= 10),
N. gamsii
FSSC 7 (
n
= 5),
N. suttoniana
FSSC 20 (
n
= 3),
F. solani sensu stricto
FSSC 5 (
n
= 2),
Fusarium
sp. FSSC 25 (
n
= 2),
Fusarium
sp. FSSC 35 (
n
= 1),
Fusarium
sp. FSSC18 (
n
= 1),
F. falciforme
FSSC 3+4 (
n
= 1),
F. pseudensiforme
(
n
= 1), and
F. solani
f.
xanthoxyli
(
n
= 1). Amphotericin B had activity against most isolates although MICs ranged from 0.5 to 32 μg mL
-1
.
Fusarium keratoplasticum
showed high MIC values (8–>32 μg mL
-1
) for itraconazole, voriconazole, posaconazole, and isavuconazole. Among agricultural fungicides, difenoconazole had the lowest activity against FSSC with MICs of >32 μg mL
-1
for all isolates.